Literature DB >> 15507518

Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery.

Luis Alberto Vázquez1, Fernando Pazos, José Ramón Berrazueta, Carlos Fernández-Escalante, María Teresa García-Unzueta, Julio Freijanes, José Antonio Amado.   

Abstract

Metabolic alterations such as insulin resistance are thought to underlie the endothelial dysfunction and low grade inflammation found in morbid obesity. Twenty-six morbidly obese patients, aged 39.0 +/- 10.0 (mean +/- sd), were evaluated before and 4.2 +/- 0.8 months after bariatric surgery. A marked increment in the insulin sensitivity index (S(I)) and the endothelium-dependent vasodilatory response in a dorsal hand vein was observed after weight loss following bariatric surgery. Circulating levels of E-selectin, P-selectin, plasminogen activator inhibitor-1, and von Willebrand factor, which were higher than those in the control group, decreased significantly after surgery. Plasma vascular cell adhesion molecule-1, angiotensin-converting enzyme, intercellular adhesion molecule-1, thrombomodulin, and plasma and intraplatelet cGMP levels did not change after weight loss. All inflammatory markers were higher in morbidly obese patients. After surgery, C- reactive protein and sialic acid diminished, whereas circulating levels of IL-6, TNF-alpha, and its soluble receptors did not. Positive correlations were found between changes in adiposity and S(I) and changes in C-reactive protein and between changes in sialic acid and changes in endothelial function. In conclusion, a marked improvement in S(I), endothelial function, and low grade inflammation was observed in the weight-losing, morbidly obese patients after bariatric surgery. S(I) and adiposity appear to play roles in obesity-related, low grade inflammation that contribute to the endothelial dysfunction observed in morbid obesity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507518     DOI: 10.1210/jc.2003-032059

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  64 in total

Review 1.  Can bariatric surgery reduce risk of Alzheimer's disease?

Authors:  Kelly M Stanek; John Gunstad
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-07-04       Impact factor: 5.067

Review 2.  Obesity, weight loss, and vascular function.

Authors:  Robert D Brook
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Vascular dysfunction in Type 2 diabetes: emerging targets for therapy.

Authors:  Yoonjung Park; Junxi Wu; Hanrui Zhang; Yong Wang; Cuihua Zhang
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-03

4.  Insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls.

Authors:  Alison J Dawson; Thozhukat Sathyapalan; Peter Sedman; Ramzi Ajjan; Eric S Kilpatrick; Stephen L Atkin
Journal:  Obes Surg       Date:  2014-03       Impact factor: 4.129

5.  Effects of two variants of Roux-en-Y Gastric bypass on metabolism behaviour: focus on plasma ghrelin concentrations over a 2-year follow-up.

Authors:  Noelia Pérez-Romero; Assumpta Serra; Maria Luisa Granada; Miquel Rull; Antonio Alastrué; Maruja Navarro-Díaz; Ramón Romero; Jaime Fernández-Llamazares
Journal:  Obes Surg       Date:  2009-12-17       Impact factor: 4.129

6.  Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity.

Authors:  Andreas M Beyer; Deng-Fu Guo; Kamal Rahmouni
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

Review 7.  The impact of obesity on the course and outcome of acute pancreatitis.

Authors:  Mohammed Abu Hilal; Thomas Armstrong
Journal:  Obes Surg       Date:  2008-01-18       Impact factor: 4.129

8.  A prospective randomized study comparing patients with morbid obesity submitted to sleeve gastrectomy with or without omentectomy.

Authors:  El Sdralis; M Argentou; N Mead; I Kehagias; Th Alexandridis; F Kalfarentzos
Journal:  Obes Surg       Date:  2013-07       Impact factor: 4.129

9.  Parameters of inflammation in morbid obesity: lack of effect of moderate weight loss.

Authors:  Eva Solá; Ana Jover; Antonio López-Ruiz; María Jarabo; Amparo Vayá; Carlos Morillas; Marcelino Gómez-Balaguer; Antonio Hernández-Mijares
Journal:  Obes Surg       Date:  2008-12-03       Impact factor: 4.129

Review 10.  Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.

Authors:  Konstantinos Tziomalos; Hariklia V Dimitroula; Niki Katsiki; Christos Savopoulos; Apostolos I Hatzitolios
Journal:  Mediators Inflamm       Date:  2010-03-07       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.